Abstract

JACC

Lots of interesting abstracts and cases were submitted for TCTAP 2022. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!

TCTAP A-002

Prognostic Relevance of High-Risk Plaque Features in Guiding Treatment Strategy

By Seokhun Yang, Doyeon Hwang, Joo Myung Lee, Eun-Seok Shin, Chang-Wook Nam, Joon-Hyung Doh, Jinlong Zhang, Hitoshi Matsuo, Takashi Kubo, Tsunekazu Kakuta, Bon-Kwon Koo

Presenter

Seokhun Yang

Authors

Seokhun Yang1, Doyeon Hwang1, Joo Myung Lee2, Eun-Seok Shin3, Chang-Wook Nam4, Joon-Hyung Doh5, Jinlong Zhang6, Hitoshi Matsuo7, Takashi Kubo8, Tsunekazu Kakuta9, Bon-Kwon Koo1

Affiliation

Seoul National University Hospital, Korea (Republic of)1, Samsung Medical Center, Korea (Republic of)2, Ulsan University Hospital, Korea (Republic of)3, Keimyung University Dongsan Medical Center, Korea (Republic of)4, Inje University Ilsan Paik Hospital, Korea (Republic of)5, The Second Affiliated Hospital Zhejiang University School of Medicine, China6, Gifu Heart Center, Japan7, Wakayama Medical University, Japan8, Tsuchiura Kyodo General Hospital, Japan9
View Study Report
TCTAP A-002
Vulnerable Plaque

Prognostic Relevance of High-Risk Plaque Features in Guiding Treatment Strategy

Seokhun Yang1, Doyeon Hwang1, Joo Myung Lee2, Eun-Seok Shin3, Chang-Wook Nam4, Joon-Hyung Doh5, Jinlong Zhang6, Hitoshi Matsuo7, Takashi Kubo8, Tsunekazu Kakuta9, Bon-Kwon Koo1

Seoul National University Hospital, Korea (Republic of)1, Samsung Medical Center, Korea (Republic of)2, Ulsan University Hospital, Korea (Republic of)3, Keimyung University Dongsan Medical Center, Korea (Republic of)4, Inje University Ilsan Paik Hospital, Korea (Republic of)5, The Second Affiliated Hospital Zhejiang University School of Medicine, China6, Gifu Heart Center, Japan7, Wakayama Medical University, Japan8, Tsuchiura Kyodo General Hospital, Japan9

Background

Although vulnerable plaque is associated with future coronary events, the criteria for plaque characteristics to warrant revascularization have not been established.

Methods

A total of 697 vessels with available coronary CT angiography (CCTA) and invasive fractional flow reserve (FFR) of CCTA-FFR registry (NCT04037163) from 9 centers of 3 countries were included. All vessels underwent FFR-guided deferred or performed revascularization that achieved final FFR > 0.80. High-risk plaque features (plaque burden ≥ 70%, minimum lumen area < 3.5mm2, low-attenuation plaque, and positive remodeling) were identified on CCTA. All FFR tracings and CCTA were analyzed by an independent core laboratory. The primary endpoint was vessel-oriented composite outcome (a composite of cardiac death, myocardial infarction, or revascularization, VOCO) at 5 years and adjudicated by an independent committee.

Results

The mean FFR was 0.81 ± 0.14. The cumulative incidence of 5-year VOCO was 7.2% in 517 deferred vessels, and 9.1 % in 180 revascularized vessels (p = 0.425). Overall VOCO incidence increased with the increasing number of high-risk plaque features (p-for-trend = 0.006), but this pattern was different between deferred and revascularized vessels. In vessels with 0 or 1, 2, 3, and 4 of high-risk plaque features, the cumulative incidence of VOCO was 4.7%, 7.7%, 19.3%, and 28.4%, respectively, (p-for-trend < 0.001) in deferred vessels, but 11.6%, 9.4%, 6.4%, and 10.0%, respectively (p-for-trend = 0.984) in revascularized vessels (Figure A). In vessels with ≥ 3 high-risk plaque features, revascularized vessels had a lower risk of VOCO than deferred vessels (HR 0.34, 95% CI 0.11 – 0.98, p = 0.045). However, in vessels with < 3 high-risk plaque features, revascularization did not show better outcomes than deferral of revascularization (HR 1.96, 95% CI 0.78 – 4.95, p = 0.153) (Figure B).

Conclusion

In vessels with multiple high-risk plaque features, clinical outcome after revascularization was better than after medical treatment alone among non-ischemia causing lesions. Thus, identifying plaque morphology can optimize treatment strategy selection.

Leave Comments